Effects of the atypical neuroleptic clozapine on micturition parameters in anesthetized rats

Neurourology and Urodynamics

Volumn 20, Issue 5, 2001, Pages 623-639

  Vera, Pedro L ^a,d   Nadelhaft, Irving ^a,b,c  

^a DEPARTMENT OF VETERANS AFFAIRS   (United States)

^b Urology Division   (United States)

^c Department of Pharmacology ^*  (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Alpha adrenergic; Bladder; Dopaminergic; External urethral sphincter; Haloperidol; L 745, 870; Muscarinic; Raclopride

Indexed keywords

3 [[4 (4 CHLOROPHENYL) 1 PIPERAZINYL]METHYL] 1H PYRROLO[2,3 B]PYRIDINE; CLOZAPINE; DOPAMINE; HALOPERIDOL; RACLOPRIDE;

ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; BLADDER CONTRACTION; BLADDER PRESSURE; BLADDER SPHINCTER; CONTROLLED STUDY; CYSTOMETRY; DRUG EFFECT; DRUG POTENCY; ELECTROSTIMULATION; FEMALE; HIGH FREQUENCY OSCILLATION; MICTURITION; NONHUMAN; PELVIC NERVE; RAT; RECEPTOR BLOCKING; URODYNAMICS;

ANESTHESIA; ANIMALS; ANTIPSYCHOTIC AGENTS; CLOZAPINE; DOPAMINE ANTAGONISTS; ELECTRIC STIMULATION; FEMALE; HALOPERIDOL; HYPOGASTRIC PLEXUS; PYRIDINES; PYRROLES; RACLOPRIDE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D4; URINARY BLADDER; URINATION; URINATION DISORDERS;

EID: 0034838141     PISSN: 07332467     EISSN: None     Source Type: Journal    
DOI: 10.1002/nau.1013     Document Type: Article

References (51)

1. A pharmacological paradigm for urinary incontinence and enuresis
2. Urodynamic findings in Parkinson's disease
3. Bladder dysfunction in schizophrenia
4. The pressure exerted by the external sphincler of the urethra when its motor nerve fibres are stimulated electrically
5. Decreased binding affinity of olanzapine and clozapine for human muscarinic receptors in intact clonal cells in physiological medium
6. Radioreceptor binding profile of the atypical antipsychotic olanzapine
7. Olanzapine: A basic science update
8. Clozapine and metabolites: Concentrations in serum and clinical findings during treatment of chronically psychotic patients
9. Neural mechanisms of impaired micturition reflex in rats with acute partial bladder outlet obstruction
10. Simultaneous recording of vesical and urethral pressure in urethane-anesthetized rats: Effect of neuromuscular blocking agents on the activity of the external urethral sphincter
11. Autonomic regulation of the urinary bladder and sex organs
12. Dopamine modulates peripheral purinergic neurotransmission through multiple presynaptic receptors: Tissue-dependent effects
13. Bladder dysfunction associated with clozapine therapy
14. Clozapine-induced urinary incontinence: Incidence and treatment with ephedrine
15. Experimental evidence for a central nervous system site of action in the effect of alpha-adrenergic blockers on the external urethral sphincter
16. Preliminary report: Detrusor hyperreflexia in schizophrenia
17. Raclopride, a new selective ligand for the dopamine-D2 receptor
18. Voiding dysfunction in Parkinson's disease
19. Reorganization of somato-urethral reflexes following spinal cord injury in the rat
20. Specific in vitro and in vivo binidng of 3H-raclopride
21. Effects of apomorphine on urinary bladder motility in anesthetized
22. Changes in bladder and external urethral sphincter function after spinal cord injury in the rat
23. Effect of α1 adrenoceptor antagonist on the urodynamics of the upper and lower urinary tract of the male rat
24. Maximizing clozapine therapy: Managing side effects
25. Clozapine: Guidelines for clinical management
26. A retrospective study of clozapine and urinary incontinence in Chinese in-patients
27. Analysis of factors involved in determining urinary bladder voiding cycle in urethan-anesthetized rats
28. S 18126 (2-[4(2,3-dihydrobenzo[1,4]dioxin-6-y])piperazin-1-y] methyl]indan-2-y]), a potent, selective and competitive antagonist at dopamine D4 receptors: An in vitro and in vivo comparison with L 745,870 (3-(4-[4-chlorophenyl]piperazin-1-y])methyl-]H)
29. Antimuscarinic properties of neuroleptics and drug-induced parkinsonism
30. The influence of afferent inputs from skin and viscera on the activity of the bladder and the skeletal muscle surrounding the urethra in the rat
31. Role of the pudendal nerves on the dynamics of micturition in the dog evaluated by pressure flow EMG and pressure flow plot studies
32. Urinary incontinence in patients receiving neuroleptics
33. Biological profile of L-745,870, a selective antagonist with high affinity for the dopamine D4 receptor
34. Effect of alpha-adrenergic blocking agent thymoxamine on the neurogenic bladder and urethra
35. Parkinsonism and Neurogenic bladder. Experimental and clinical observations
36. Neuroleptic affinities for human brain receptors and their use in predicting adverse effects
37. Electromyographic evaluation of the external urethral sphincter during cystometry in male cats
38. Experimental study on the micturition mechanism - The role of the pudendal nerve on the dynamics of micturition in the decerebrated dog
39. Dopamine receptor pharmacology
40. Effect of the optimal isomers of YM-12617 on increased intra-urethral pressure induced by phenylephrine in anesthetized dogs
41. The changes in the activity of pudendal motorneurons in relation to reflex micturition evoked in decerebrate cats
42. Evidence for a central monoaminergic influence on urinary bladder control mechanism
43. On the localization and mediation of the centrally induced hyperactive urinary bladder response to L-dopa in the rat
44. 1-adrenoceptor antagonists on urinary bladder function in urethane-anesthetized rats
45. The effect of bilateral pudendal blockade on the adjunctive urethral closure forces in healthy females
46. The urethral resistance to rapid dilatation: An analysis of the effect of autonomic receptor stimulation and blockade of pudendal nerve blockade in healthy females
47. Phenothiazine-induced stress incontinence
48. Clozapine and urinary incontinence
49. Analysis of pressure/flow characteristics in the female rat and their pharmacologic modulation
50. Glutamatergic and dopaminergic contributions to rat bladder hyperactivity after cerebral artery occlusion
51. Dopamine D-1 receptor-mediated inhibition of micturition reflex by central dopamine from the substantia nigra